Agile Therapeutics Inc

General ticker "AGRX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $8.4M

Agile Therapeutics Inc does not follow the US Stock Market performance with the rate: -29.3%.

Estimated limits based on current volatility of 0.9%: low 1.49$, high 1.52$

Factors to consider:

  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [6.25$, 20.82$]
  • 2023-12-31 to 2024-12-30 estimated range: [5.03$, 14.27$]

Financial Metrics affecting the AGRX estimates:

  • Negative: Non-GAAP EPS of -345.00 <= 0.08
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: negative Net Income
  • Negative: Operating Cash Flow per share of -83.17 <= 0.20
  • Negative: Industry Operating Cash Flow per share (median) of -0.72 <= 0.28
  • Negative: Industry Earnings per Price (median) of -0.21 <= 0.01
  • Negative: Interest Expense per share of 7.24 > 0.85

Similar symbols

Short-term AGRX quotes

Long-term AGRX plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.75MM $4.10MM $0.00MM
Operating Expenses $49.80MM $75.11MM $52.56MM
Operating Income $-49.05MM $-71.00MM $-52.56MM
Non-Operating Income $-2.80MM $-0.06MM $22.47MM
Interest Expense $3.11MM $3.91MM $3.13MM
R&D Expense $13.50MM $6.25MM $3.25MM
Income(Loss) $-51.85MM $-71.07MM $-30.09MM
Taxes $0.00MM $0.00MM $-4.67MM
Profit(Loss) $-51.85MM $-71.07MM $-25.41MM
Stockholders Equity $49.33MM $3.92MM $-5.54MM
Assets $73.06MM $39.33MM $14.24MM
Operating Cash Flow $-47.31MM $-65.20MM $-35.95MM
Investing Cash Flow $-40.69MM $39.46MM $-0.13MM
Financing Cash Flow $67.98MM $30.42MM $22.18MM
Earnings Per Share* $-1,291.56 $-63,115.49 $-58.79

* EPS are Split Adjusted, recent splits may be reflected with a delay.